Infectious Diseases 1703 - Infectious Disease Alert - Mar 01, 2013

Target Audience:

This activity is intended for the infectious disease specialist.


Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University
Hospital Epidemiologist
Sequoia Hospital
Redwood City, CA

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Section Editor Updates
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Medical Center

Associate Editors
Richard R. Watkins, MD, MS, FACP
Division of Infectious Diseases
Akron General Medical Center
Akron, OH
Associate Professor of Internal Medicine,
Northeast Ohio Medical University
Rootstown, OH

Hal B. Jenson, MD, FAAP
Western Michigan University School of Medicine
Kalamazoo, MI

Joseph F John, Jr., MD, FACP, FIDSA, FSHEA
Associate Chief of Staff for Education
Ralph H. Johnson Veterans Administration Medical Center
Professor of Medicine
Medical University of South Carolina

Dean L. Winslow, MD, FACP, FIDSA
Chairman, Department of Medicine
Santa Clara Valley, Medical Center
Clinical Professor
Stanford University School of Medicine

Betty Tran, MD, MS
Assistant Professor of Medicine
Pulmonary and Critical Care Medicine
Rush University Medical Center


  • Continuous Infusion of Beta-lactams for Sepsis Improves Outcomes
  • Antibiotics for Severe Acute Malnutrition
  • Malaria Continues to Take Staggering Toll as Relief Efforts Plateau
  • Burden of Human Metapneumovirus Infection in Young Children
  • Doxycycline May Protect Against Clostridium Difficile Infection
  • Direct-acting antivirals for hepatitis C show promise
  • Updates


  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck. Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck. Peer Reviewer Timothy Jenkins, MD, Associate Editor Richard R. Watkins, MD, MS, FACP, Hal B. Jenson, MD, FAAP), Joseph F John, Jr., MD, FACP, FIDSA, FSHEA, and Author Betty Tran MD, MS report no financial relationship relavent to this field of study. Associate Editor Dean L. Winslow, MD, FACP, FIDSA is a consultant for Siemens Diagnostic..

Copyright 2013 AHC Media. All rights reserved.